H.R. 1, or the Big Beautiful Bill, has brought substantial change to the managed care pharmacy landscape, particularly for managed care organizations (MCOs) with managed Medicaid lines of business.
AMCP Comment Letter on Medicare Drug Price Negotiation Program Draft Guidance
AMCP recognizes the importance of efforts to make prescription drugs more affordable for Medicare beneficiaries and urges CMS to continually and rigorously oversee the program’s implementation and its broader effects to ensure that it does not unintentionally hinder innovation and the development of new therapies. CMS should monitor the downstream impact of the Medicare Drug Price Negotiation Program on innovation and drug development and take appropriate action as needed to ensure that the United States remains the leader in pharmaceutical innovation.
Related
HealthyWomen, members of its HPV Coalition and additional stakeholders are writing the Advisory Committee on Immunization Practices (ACIP) regarding the upcoming June ACIP meeting June 25-27, 2025, docket number - CDC-2005-0024.
Today, Senator Josh Hawley (R-MO) introduced legislation that would rollback some of the impending cuts to federal Medicaid funding as mandated by H.R. 1.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
